Hyphenated Mass Spectrometry-Based Strategies for Characterizing Oligomers of α-Synuclein in Parkinson’s Disease
ACS Central Science · 23.09.2026 · 12 (9) · 1360-1371
DOI: 10.1021/acscentsci.6c00514 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 20.08.2026. Verfasst von Raya Sadighi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of BioAnalytical Chemistry, Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences, Vrije U…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The pathological aggregation of α-synuclein (α-syn), an intrinsically disordered protein that regulates synaptic vesicle trafficking in the brain, is a defining molecular feature in Parkinson’s disease (PD). Early oligomeric assemblies are widely considered the most neurotoxic species, yet their structural features remain unexplored due to their low abundance, transient, and fragile nature. Here, we establish a trapped ion mobility-mass spectrometry (TIMS-MS) strategy that enables direct detection and structural interrogation of these oligomers. Low-flow size exclusion chromatography provides MS-compatible desalting and reveals broad ensemble-level differences between fresh and aggregated α-syn. Native TIMS-MS measurements uniquely probe numerous higher-order oligomers, thereby revealing a reduced conformational heterogeneity with increasing oligomer size, supporting a linear β-strand-type assembly pathway. These findings show that oligomerization drives a transition from dynamic monomers to increasingly ordered intermediates. This progressive rigidification is relevant to models in which α-syn oligomerization alters normal membrane engagement during PD-associated aggregation.
Autor:innen und Institutionen
- Division of BioAnalytical Chemistry, Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Nethe…
- Centre for Analytical Sciences Amsterdam (CASA), The Netherlands.
- Syngle Therapeutics B.V., https://www.syngletherapeutics.com/, The Netherlands.
ORCID-Profile: Melissa Baerenfaenger, Anouk M Rijs
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Sadighi, R., Istrati, A., Karijodikoro, S., Scheefhals, G., Baerenfaenger, M., & Rijs, A. M. (2026). Hyphenated Mass Spectrometry-Based Strategies for Characterizing Oligomers of α-Synuclein in Parkinson’s Disease. ACS Central Science, 12(9), 1360-1371. https://doi.org/10.1021/acscentsci.6c00514
Vancouver
Sadighi R, Istrati A, Karijodikoro S, Scheefhals G, Baerenfaenger M, Rijs AM. Hyphenated Mass Spectrometry-Based Strategies for Characterizing Oligomers of α-Synuclein in Parkinson’s Disease. ACS Central Science. 2026;12(9):1360-1371. doi:10.1021/acscentsci.6c00514
BibTeX
@article{Sadighi2026,
author = {Sadighi, Raya and Istrati, Andrea and Karijodikoro, Sigourney and Scheefhals, Guus and Baerenfaenger, Melissa and Rijs, Anouk M},
title = {Hyphenated Mass Spectrometry-Based Strategies for Characterizing Oligomers of α-Synuclein in Parkinson’s Disease},
journal = {ACS Central Science},
year = {2026},
volume = {12},
number = {9},
pages = {1360--1371},
doi = {10.1021/acscentsci.6c00514}
}
EUVIMED